Bonviva 150Mg Tab 1's
Bonviva 150Mg Tab 1's

Bonviva 150Mg Tab 1's

8.82 KWD

01

Shop & Discover More

Sold out
product image
F. Hoffmann-La Roche Ltd

Bonviva 150Mg Tabs 3's

20.11Kwd
Key Features

Bonviva 150 mg Tablets contain ibandronic acid, a bisphosphonate medicine used in the treatment of osteoporosis in postmenopausal women. It helps strengthen bones and reduce the risk of fractures by slowing bone loss.

Usage Instructions

Take one tablet once monthly as prescribed by a healthcare professional. The tablet should be taken with a full glass of plain water, on an empty stomach, at least 60 minutes before the first food or drink of the day. Remain upright for at least one hour after taking the tablet.

Clinical Evidence

Ibandronic acid has been clinically proven to increase bone mineral density and reduce bone turnover in patients with osteoporosis. It is widely used in clinical practice for long-term osteoporosis management.

Other Ingredients / Materials

Active ingredient: ibandronic acid 150 mg. Contains standard pharmaceutical excipients used in tablet formulation to ensure stability and proper absorption.

Benefits

Helps reduce bone loss, supports increased bone strength, lowers the risk of fractures, and provides convenient once-monthly dosing for osteoporosis management.

Made in

Germany